---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-016026"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T07:18:15.917274+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NextCure files IND for product candidate LNCB74

## Summary
- Filed Investigational New Drug application with FDA for LNCB74.
- Updated corporate presentation to reflect the IND filing.
- Company engaging with investment community starting December 5, 2024.

## SEC filing metadata
- accession: 0001558370-24-016026
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000155837024016026/0001558370-24-016026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000155837024016026/nxtc-20241205x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-016026
- JSON: https://secwatch.observer/filing/0001558370-24-016026.json
- Plain text: https://secwatch.observer/filing/0001558370-24-016026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.